Clinical Trials Browser

Phase 3 × OTHER × CPX-351 × Clear all

NCT03897127 2025-07-17

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

Phase 3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute